Medical debt is the largest US debt in collections. Erasing it changed little.
Americans owed about $140 billion in medical bills in collections. But two randomized experiments that relieved debt found no average effect on credit, financial distress or mental health.
Medical debt is the single largest category of debt Americans owe to collection agencies — an estimated $140 billion as of mid-2020, more than all other kinds of debt in collections combined [s1]. That figure has fueled a wave of programs that buy up and cancel medical debt. But when researchers ran the rigorous test — randomly relieving some people's medical debt and not others' — they found something uncomfortable: on average, erasing the debt did not measurably improve people's finances or their mental health [s2]. The scale of the problem and the disappointing result of the obvious fix are both true, and both worth knowing.
How big the problem is
The $140 billion figure comes from a study published in JAMA in 2021, which analyzed a large, nationally representative sample of consumer credit reports from the credit bureau TransUnion covering January 2009 through June 2020 [s1]. It found that medical debt had become the largest source of debt in collections in the United States, and that roughly 18% of Americans held medical debt in collections [s1]. Because the data predates the pandemic, it reflects ordinary US health care, not a crisis surge.
The study also found the burden was not evenly spread. Medical debt was concentrated in lower-income communities and, notably, was substantially higher in states that had not expanded Medicaid under the Affordable Care Act — a pattern consistent with the idea that broader insurance coverage reduces the medical bills that end up in collections [s1]. That geographic split is one of the clearest signals in the data that medical debt is downstream of how people are, or are not, insured.
Association is not causation
It is tempting to move directly from "people with medical debt are worse off" to "medical debt makes people worse off." Plenty of studies document that people carrying medical debt report more forgone care, more financial stress, and worse mental health. But those are associations, and they run into an obvious confound: the people who accumulate large medical debts are, on average, sicker, poorer, and more precarious to begin with. Their worse outcomes could be caused by the underlying illness and hardship rather than by the debt itself. Distinguishing the two requires an experiment — actually removing the debt from some people and comparing them with otherwise similar people whose debt was left in place.
The experiment, and its surprising result
That is what a team of economists did, partnering with the charity RIP Medical Debt to run two randomized experiments. They relieved medical debt with a face value of $169 million for 83,401 people between 2018 and 2020, chosen at random from a larger pool, and tracked outcomes using credit reports, collections data, and a detailed survey [s2].
The results, reported in a 2024 National Bureau of Economic Research working paper, were close to null. Debt relief had no measurable effect on credit access, credit utilization, or financial distress on average [s2]. It produced a moderate, statistically significant reduction in how much of their existing medical bills people paid — that is, relieved people paid down somewhat less of their remaining medical debt — and it had no effect on mental health on average, with the pre-registered analysis even finding detrimental effects for some subgroups [s2]. In plain terms: canceling the debt did not lift the financial or psychological weight the way almost everyone, including the researchers, expected it to.
This is exactly the kind of finding that gets buried, because it is unsatisfying and cuts against a popular remedy. It deserves to be reported plainly. It does not mean medical debt is harmless or that relief is pointless for the individuals freed of a specific obligation. What it means is narrower and more precise: buying up already-defaulted medical debt, after the fact, does not appear to be an effective lever for improving the average recipient's financial security or health — likely because by the time a bill is in collections, much of the damage (to credit, to care decisions, to stress) has already been done, and canceling the paper obligation does not reverse it.
What the evidence supports
Two things hold at once. Medical debt is genuinely enormous in aggregate — the largest debt in US collections, touching nearly one in five Americans, and concentrated where insurance coverage is thinnest [s1]. And the most rigorous test of relieving it found little average benefit, which points away from downstream debt forgiveness and toward preventing the bills — through insurance coverage and limits on how aggressively they are pursued — as the more promising place to intervene [s2]. The uncomfortable synthesis is that the size of the medical-debt problem and the ineffectiveness of the most intuitive solution are both well supported by evidence, and any honest account has to carry both.
Sources
- Medical Debt in the US, 2009-2020 — JAMA , July 20, 2021
- The Effects of Medical Debt Relief: Evidence from Two Randomized Experiments — National Bureau of Economic Research (Working Paper 32315) , April 1, 2024
A drug's 'price' is two different numbers, and the gap can be enormous
The list price is the sticker; the net price is what the maker keeps after rebates. For one insulin, list rose 27% over five years as the net price fell 10%. Who you are decides which you pay.
Three companies you've never chosen decide much of what your drugs cost
Pharmacy benefit managers sit between you, your insurer and the pharmacy. The three largest process nearly 80% of US prescriptions, and a federal regulator says the structure can raise costs.
The same operation at one hospital can cost thousands more on another plan
Since 2021, hospitals must post the rates they negotiate with each insurer. The data confirms the same procedure at the same hospital varies widely by which insurer is paying.
Prior authorization delays care. A federal audit shows some denials are wrong.
Physician surveys report delays and abandoned treatment; those are self-reported. A harder number: a federal audit found 13% of Medicare Advantage denials met Medicare's own coverage rules.